

Butterbur, Butter dock, Bog rhubarb, Exwort
ZE 339 (a standardized carbon dioxide extract of butterbur that contains 8mg petasine, Petadolex
Butterbur is an herb native to Europe, south western Asia, and north Africa. The leaf and root extracts of Butterbur have been used to treat allergies, bronchial asthma, headache, pain, and muscle and urinary tract spasms. Petasins, the sesquiterpene compounds found in Butterbur, are thought to be the active constituents (1) (2) (3).
Leaf and root extracts of Butterbur are effective in controlling migraines in adults and in children (4) (5) (6) (17) (19) and asthma (7). Butterbur extract may also be effective against somatoform disorders (20).
But results from studies on allergic diseases are mixed. Some studies suggest the efficacy of Butterbur extract is comparable to standard antihistamine drugs (8) (9) (10) for allergic rhinitis but conflicting data indicate that it is no better than placebo for intermittent rhinitis (11) or for allergic skin disease (12). A systematic review of trials suggests the need for more rigorous studies before recommending use of Butterbur (13).
Raw butterbur extract may contain excessive toxic pyrrolizidine alkaloids that can cause liver damage (14).
The sesquiterpene petasin is thought to be responsible for butterbur's anti-inflammatory and antiallergic effects by blocking leukotriene and histamine activities (15). Petasins were also shown to have calcium channel blocking effects (18) making them effective for migraine prophylaxis (1). The vasorelaxation effects of petasin may be via direct Ca(2+) antagonism of L-type voltage-dependent Ca(2+) channel (VDCC) in vascular smooth muscle (21). Butterbur extract showed dose-dependent inhibition effect on cyclooxygenase (COX2) and prostaglandin E2 in vitro that is not correlated to the petasin content (16).
Grossman W, Schmidramsl H. An extract of Petasites hybridus is effective in the prophylaxis of migraine. Altern Med Rev 2001;6(3):303-10.
Sixty patients with migraine received either butterbur extract or placebo 50 mg twice daily for 12 weeks. Compared to baseline, the frequency of attacks with butterbur decreased by a maximum of 60%. Results were also significant in favor of butterbur extract for the prevention of migraines compared to placebo (p<0.05). Butterbur was well tolerated with no adverse effects.
Danesch UC. Petasites hybridus (Butterbur root) extract in the treatment of asthma—an open trial. Altern Med Rev 2004;9(1):54-62.
In a prospective, non-randomized open trial, 80 patients were treated for two months with butterbur extract followed by two months of optimal intake of extract. Patients had either mild or moderate asthma and were allowed to continue to receive their asthma medication. The number, duration, and severity of asthma attacks decreased, while peak flow, forced ecpiratory volume (FEV1) and all measured symptoms improved during therapy. Forty percent of patients who were receiving asthma medications reduced their intake of the medications during the course of the study. Adverse events were considered not related to the use of butterbur and did not lead to withdrawal of any subjects in the study.
Lee DK, Gray RD, Robb FM, et al. A placebo-controlled evaluation of butterbur and fexofenadine on objective and subjective outcomes in perennial allergic rhinitis. Clin Exp Allergy 2004;34(4):646-9.
In a double-blind crossover placebo-controlled trial, 16 patients were randomized to receive butterbur 50 mg twice a day, fexofenadine 180 mg, or placebo. Peak nasal inspiratory flow (PNIF) was evaluated. There was a significant PNIF fall from baseline with butterbur compared to placebo. There was also a reduction in total nasal symptoms. Authors conclude that butterbur and fexofenadine may be equally effective in improving nasal symptoms in allergic rhinitis.
Bottom Line: Butterbur extracts have been shown effective in the treatment of migraines and allergies.
Butterbur is an herb native to Europe, southwestern Asia, and north Africa. It has been used to treat allergies, asthma, headache, and muscle spasms. Butterbur was shown in clinical studies to be effective for migraines, allergic rhinitis (runny nose), and asthma.
MigraineIn this study, 60 patients with migraine were randomized to receive 50 mg of butterbur extract or placebo twice daily for 12 weeks. Researchers observed that the frequency of migraine attacks decreased by 60% in the treatment group compared to those who took placebo.
Allergic rhinitis
In a double-blind, placebo-controlled, crossover study, 35 patients received butterbur 50 mg twice daily or placebo for two weeks for the treatment of intermittent allergic rhinitis. Peak nasal inspiratory flow was the primary outcome variable. Results showed that butterbur had no significant effect compared to placebo.